Closed
SectorHealthcare
316.82 -2.26
24h
Min
315.59
Max
327.61
Income | 26M -57M |
---|---|
Sales | 1M 594M |
EPS | -0.01 |
Profit margin | -9.674 |
Employees | 2,230 |
EBITDA | 166M 11M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +5.03% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | 8.4B 43B |
---|---|
Previous open | 319.08 |
Previous close | 316.82 |
By Acuity
50%
50%
143 / 375 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 340.43 USD 5.03%
High 500 USD
Low 245 USD
Based on 23 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$